Prevalence of Microalbuminuria Among Diabetes Patients in Africa: A Systematic Review and Meta-Analysis
Open Access
- 11 July 2023
- journal article
- review article
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 16, 2089-2103
Abstract
Background: Microalbuminuria (MAU) is considered the earliest sign of diabetic nephropathy among diabetes patients. In order to effectively manage diabetic nephropathy and its consequences early, detection of microalbuminuria as soon as possible, especially for diabetes patients, is critical. Therefore, the present study aimed to determine the pooled prevalence of microalbuminuria among diabetes patients in Africa. Methods: Electronic databases such as Google Scholar, PubMed, African Journals Online, Web of Science, Cochrane Library, EMBASE, and ResearchGate were searched for articles and grey literature. The STATA version 14 software was used to conduct the meta-analysis. I2 and Cochran’s Q test were employed to assess the presence of heterogeneity between studies. Due to the presence of heterogeneity, a random effect model was used. The publication bias was assessed using the symmetry of the funnel plot and Egger’s test statistics. Moreover, subgroup analysis, trim and fill analysis, and sensitivity analysis were also done. Results: The overall pooled prevalence of microalbuminuria among diabetes patients in Africa was 37.11% (95% CI 31.27– 42.95). Substantial heterogeneity was observed between studies, with I2 values of 94.7%. Moreover, this meta-analysis showed that the pooled estimate of microalbuminuria among type 1 and type 2 diabetes patients was 35.34% (95% CI: 23.89– 46.80, I2=94.2), and 40.24% (95% CI: 32.0– 48.47, I2=94.9) respectively. MAU, on the other hand, was more common in people with diabetes for more than 5 years 38.73% (95% CI: 29.34– 48.13) than in people with diabetes for less than 5 years 31.48% (95% CI: 18.73– 44.23). Conclusion: This systematic review and meta-analysis found a high prevalence of microalbuminuria among diabetes patients. As a result, early detection of microalbuminuria is critical for preventing and treating microvascular complications such as diabetic nephropathy and the onset of end-stage renal disease.Keywords
This publication has 82 references indexed in Scilit:
- The Impacts of Albuminuria and Low eGFR on the Risk of Cardiovascular Death, All-Cause Mortality, and Renal Events in Diabetic Patients: Meta-AnalysisPLOS ONE, 2013
- Long-term Renal Outcomes of Patients With Type 1 Diabetes Mellitus and MicroalbuminuriaAn Analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications CohortMicroalbuminuria Outcomes in Type 1 DiabetesArchives of internal medicine (1960), 2011
- Standards of Medical Care in Diabetes—2010Diabetes Care, 2010
- Renal function in diabetic nephropathyWorld Journal of Diabetes, 2010
- Diabetic nephropathyDiabetology & Metabolic Syndrome, 2009
- Microalbuminuria in diabetes mellitus: Association with age, sex, weight, and creatinine clearanceIndian Journal of Nephrology, 2009
- Prevalence and determinants of microalbuminuria among diabetic patients in the United Arab EmiratesBMC Nephrology, 2008
- Prevalence of microalbuminuria and its risk factors in type 2 diabetic patientsIndian Journal of Nephrology, 2008
- Measuring inconsistency in meta-analysesBMJ, 2003
- Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patientsDiabetologia, 1991